Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has announcements
×
Ramucirumab
×
Gastrointestinal
×
Clear all
Filters
3
NCT02435433
2023-01-20
REACH-2
Eli Lilly and Company
Phase 3
Completed
399 enrolled
22 charts
1 FDA